A novel TNFα antagonizing peptide-Fc fusion protein designed based on CDRs of TNFα neutralizing monoclonal antibody
Authors:
- Weisong QinWQWeisong Qin
- Jiannan FengJFJiannan Feng
- Wei ZhangWZWei Zhang
- Yan LiYLYan Li
- Beifen ShenBSBeifen Shen
- 1 September 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 322 (3) , 1024-1028
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Anti-TNF-?-induced systemic lupus syndromeClinical Rheumatology, 2003
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- Anti‐TNF agents for rheumatoid arthritisBritish Journal of Clinical Pharmacology, 2001
- A phage‐displayed mimotope inhibits tumour necrosis factor‐α‐induced cytotoxicity more effectively than the free mimotopeImmunology, 1999
- Immunoadhesins: principles and applicationsTrends in Biotechnology, 1996
- Identification and characterization of a TNFα antagonist derived from a monoclonal antibodyMolecular Immunology, 1994
- Identification of the binding site of 55kda tumor necrosis factor receptor by synthetic peptidesBiochemical and Biophysical Research Communications, 1992
- The cytokine networkImmunology Today, 1989
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985